PL EN


Preferences help
enabled [disable] Abstract
Number of results
2016 | 27 | 106 | 40-46
Article title

Sacred and magic – the past and the present of hallucinogenic mushrooms containing psilocybin and its derivatives

Content
Title variants
PL
Święte i magiczne – pradawne i obecne gatunki grzybów halucynogennych zawierających psylocybinę i jej pochodne
Languages of publication
PL
Abstracts
EN
Mushrooms containing hallucinogenic indole compounds are one of the sources of psychoactive substances which are found in nature. These species contain indole derivatives such as for example psilocybin, a naturally occurring hallucinogen. The potential of these compunds for occasioning altered states of consciousness has probably been known by human kind from the very beginning, which is indicated by the ancient findings. The aim of this article is to address the issue of using hallucinogenic mushrooms in purpose of altering consciousness. This work presents a brief report of marks for the ancient use of hallucinogenic mushrooms and other hallucinogens, and discusses the matter of religious experiences facilitated by the use of hallucinogenic indole derivatives. Finally, the controversies over the hallucinogenic substances are taken under consideration.
Discipline
Publisher

Year
Volume
27
Issue
106
Pages
40-46
Physical description
Contributors
  • Zakład Ontologii, Instytut Filozofii, Wydział Filozoficzny, Uniwersytet Jagielloński, Kraków, j.szelegieniec@gmail.co
  • Zakład Ontologii, Instytut Filozofii, Wydział Filozoficzny, Uniwersytet Jagielloński, Kraków
References
  • 1. Revonsuo, A.; Kallio, S.; Sikka, P.;. Philos. Psychol. 2009, 22(2), 187-204.
  • 2. Ustinova, J.; w: Cardeña, E.; Winkelman, M. (red.); Praeger Publishers, Santa Barbara, CADenver, CO-Oxford, 2011, 45-72.
  • 3. Presti, D. E.; W: Cardeña, E.; Winkelman, M., (red.); Praeger Publishers, 2011, 21-41.
  • 4. Allen, J. W.; Arthur, J.; W: Metzner, R.; Darling, D.C., (red.); Park Street Press, 2005, 49-68.
  • 5. Blom, J. D. (red.); Springer, New York-DordrechtHeidelberg-London, 2010.
  • 6. Gartz, J.; LIS Publications, Los Angeles, CA, 1996.
  • 7. Guzmán, G.; Allen, J. W.; Gartz, J.;. Ann. Mus. civ. Rovereto. 1998, 14, 189-280.
  • 8. Passie, T.; Seifert, J.; Schneider, U.; Emrich, H. M.;. Addict. Biol. 2002, 7(4), 357-364.
  • 9. Nichols, D. E.;. Pharmacol. Ther. 2004, 101(2), 131181.
  • 10. Nichols, D. E.; Chemel, B. R.;. W: McNamara, P., (red.); Praeger Publishers, Wesport, CT-London, 2006, 1-33.
  • 11. Frecska, E.; Luna, L.E.;. Neuropsychopharmacol. Hung. 2006, 8(4), 189-200.
  • 12. Winkelman, M.; Praeger Publishers, Santa Barbara, CA, 2010.
  • 13. Winkelman, M.; W: Walter, M. N.; Neumann Fridman, E. J., (red.); ABC Clio, Oxford, 2004, 6170.
  • 14. Whitley, D. S.; W: Walter, M. N.; Neumann Fridman, E. J., (red.); ABC Clio, Oxford, 2004, 1620.
  • 15. Winkelman, M.;. Zygon. 39(1), 193-217.
  • 16. Metzner, R.;. J. Psychoactive Drugs. 1998, 30(4), 333-341.
  • 17. Guerra-Doce, E.;. Time and Mind: J. Archaeol. Conscious. Cultur. 2015, 8(1), 91-112.
  • 18. Tayade, S. K.; Dhale, D. A.; Patil, D. A.;. J. Ethnobiol. Traditional Med. 2013, 118, 340-351.
  • 19. Schultes, R. E.;. Heffter Rev. Psychedelic Res. 1998, 1, 1-7.
  • 20. Terry, M.; Steelman, K. L.; Guilderson, T.; Dering, P.; Rowe, M. W.;. J. Archaeol. Sci. 2006, 33(7), 10171021.
  • 21. Samorini, G.;. Integration. 1992, 2/3, 69-78.
  • 22. Guzmán, G.;. Acta Bot. Mex. 2012, 100, 79-106.
  • 23. Akers, B. P.; Ruiz, J. F.; Piper, A.; Ruck, C. A.;. Econ. Bot. 2011, 65(2), 121-128.
  • 24. Guerra-Doce, E.;. J. Archaeol. Method Theory. 2015, 22, 751-782.
  • 25. Ott, J.;. Natural Products Co., Kennewick, WA, 1996.
  • 26. Griffiths, R. R.; Johnson, M. W.; Richards, W. A.; Richards, B. D.; McCann, U.; Jesse, R.;. Psychopharmacology. 2011, 218(4), 649-665.
  • 27. Doblin, R.;. J. Transpersonal Psychol. 1991, 23(1), 1-28.
  • 28. MacLean, K. A.; Johnson, M. W.; Leoutsakos, J.-M. S.; Griffiths, R. R.;. J. Sci. Study Relig. 2012, 51(4), 721-737.
  • 29. Grob, C. S.; Danforth, A. L.; Chopra, G. S.; Hagerty, M.; McKay, C. R.; Halperstadt, A. L. ; et al.;. Arch Gen Psychiatry. 2011, 68(1), 71-78.
  • 30. http://www.clinicaltrials.gov/ct2/show/study/ NCT00465595term=Psilocybin&rank=5.
  • 31. Moreno, F.; Wiegand, C. B.; Taitano, E. K.; Delgado, P. L.;. J. Clin. Psychiatry. 2006, 67(11),
  • 32. Vollenweider, F. X.; Kometer, M.;. Nat. Rev. Neurosci. 2010, 11, 642-651.
  • 33. Carhart-Harris, R. L.; Leech, R.; Williams, T. M.; Erritzoe, D.; Abbasi, N.; Bargiotas, T.; et al.;. Br. J. Psychiatry. 2012, 200, 238-244.
  • 34. Spilane, J.; McAllister, W. B.;. Drug Alcohol. Depend. 2003, 70(3 Supp), 5-12.
  • 35. James, W.; Wydawnictwo Nomos, Kraków, 2011. Eliade, M.; Wydawnictwo Aletheia,
  • Warszawa, 2011.
  • 36. Rostkowska-Nadolska, B.; Machoń, Z.;. Toksykologia. 2009, 65, 2, 138-146.
Document Type
review
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.psjd-a0f6c6bd-67f0-4daf-a55f-a2e253f693e5
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.